Luye Pharma Holdings Ltd. - Net Worth and Insider Trading
Luye Pharma Holdings Ltd. Net Worth
The estimated net worth of Luye Pharma Holdings Ltd. is at least $3.6 Billion dollars as of 2024-06-22. Luye Pharma Holdings Ltd. is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd and owns about 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) stock worth over $3.6 Billion. Details can be seen in Luye Pharma Holdings Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Luye Pharma Holdings Ltd. has not made any transactions after 2024-04-10 and currently still holds the listed stock(s).
Transaction Summary of Luye Pharma Holdings Ltd.
Luye Pharma Holdings Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Luye Pharma Holdings Ltd. owns 1 companies in total, including Luye Pharma Group Ltd (HKSE:02186) .
Click here to see the complete history of Luye Pharma Holdings Ltd.’s form 4 insider trades.
Insider Ownership Summary of Luye Pharma Holdings Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02186 | Luye Pharma Group Ltd | 2024-04-10 | 2201 Interest of corporation controlled by you |
Luye Pharma Holdings Ltd. Latest Holdings Summary
Luye Pharma Holdings Ltd. currently owns a total of 1 stock. Luye Pharma Holdings Ltd. owns 1,259,196,703 shares of Luye Pharma Group Ltd (HKSE:02186) as of April 10, 2024, with a value of $3.6 Billion.
Latest Holdings of Luye Pharma Holdings Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02186 | Luye Pharma Group Ltd | 2024-04-10 | 1,259,196,703 | 2.84 | 3,576,118,637 |
Holding Weightings of Luye Pharma Holdings Ltd.
Luye Pharma Holdings Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Luye Pharma Holdings Ltd. has made a total of 12 transactions in Luye Pharma Group Ltd (HKSE:02186) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Luye Pharma Group Ltd is the sale of 0 shares on April 10, 2024, which brought Luye Pharma Holdings Ltd. around $0.
Insider Trading History of Luye Pharma Holdings Ltd.
- 1
Luye Pharma Holdings Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Luye Pharma Holdings Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Luye Pharma Holdings Ltd. is -16.72%. GuruFocus also compares Luye Pharma Holdings Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Luye Pharma Holdings Ltd. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Luye Pharma Holdings Ltd.'s insider trading performs compared to the benchmark.
Performance of Luye Pharma Holdings Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.49 |  | | | | |
| Relative Return to S&P 500(%) | -27.47 | | | | | |
Luye Pharma Holdings Ltd. Ownership Network
Luye Pharma Holdings Ltd. Owned Company Details
What does Luye Pharma Group Ltd do?
Who are the key executives at Luye Pharma Group Ltd?
Luye Pharma Holdings Ltd. is the 2201 Interest of corporation controlled by you of Luye Pharma Group Ltd. Other key executives at Luye Pharma Group Ltd include 2201 Interest of corporation controlled by you UBS Group AG , 2301 Trustee Liu Dianbo , and 2101 Beneficial owner LuYe Pharmaceutical Investment Co., Ltd. .
Luye Pharma Group Ltd (HKSE:02186) Insider Trades Summary
Over the past 18 months, Luye Pharma Holdings Ltd. made 10 insider transaction in Luye Pharma Group Ltd (HKSE:02186) with a net purchase of 2,000,000. Other recent insider transactions involving Luye Pharma Group Ltd (HKSE:02186) include a net sale of 73,433,500 shares made by UBS Group AG , a net purchase of 2,000,000 shares made by Liu Dianbo , and a net purchase of 2,000,000 shares made by LuYe Pharmaceutical Investment Co., Ltd. .
In summary, during the past 3 months, insiders sold 0 shares of Luye Pharma Group Ltd (HKSE:02186) in total and bought 3,569,500 shares, with a net purchase of 3,569,500 shares. During the past 18 months, 77,003,000 shares of Luye Pharma Group Ltd (HKSE:02186) were sold and 26,200,500 shares were bought by its insiders, resulting in a net sale of 50,802,500 shares.
Luye Pharma Group Ltd (HKSE:02186)'s detailed insider trading history can be found in Insider Trading Tracker table.
Luye Pharma Group Ltd Insider Transactions
Luye Pharma Holdings Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Luye Pharma Holdings Ltd.. Currently GuruFocus does not have mailing address information for Luye Pharma Holdings Ltd..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
